OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011
David Asboe, Campbell Aitken, Marta Boffito, et al.
HIV Medicine (2011) Vol. 13, Iss. 1, pp. 1-44
Closed Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

CRISPR-based diagnostics
Michael M. Kaminski, Omar O. Abudayyeh, Jonathan S. Gootenberg, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 7, pp. 643-656
Closed Access | Times Cited: 845

HIV and cardiovascular disease
Kaku So‐Armah, Laura Benjamin, Gerald S. Bloomfield, et al.
The Lancet HIV (2020) Vol. 7, Iss. 4, pp. e279-e293
Open Access | Times Cited: 220

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012
Ian Williams, Duncan Churchill, Jane Anderson, et al.
HIV Medicine (2012) Vol. 13, Iss. S2, pp. 1-6
Open Access | Times Cited: 215

Recommendations for Evaluation and Management of Bone Disease in HIV
Todd T. Brown, Jennifer Hoy, Marco Borderi, et al.
Clinical Infectious Diseases (2015) Vol. 60, Iss. 8, pp. 1242-1251
Open Access | Times Cited: 168

Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review
James McMahon, Julian Elliott, Silvia Bertagnolio, et al.
Bulletin of the World Health Organization (2013) Vol. 91, Iss. 5, pp. 377-385E
Open Access | Times Cited: 143

Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients
Patrick Ryscavage, Sean G. Kelly, Jonathan Z. Li, et al.
Antimicrobial Agents and Chemotherapy (2014) Vol. 58, Iss. 7, pp. 3585-3598
Open Access | Times Cited: 123

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015
Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
HIV Medicine (2016) Vol. 17, Iss. S4
Open Access | Times Cited: 121

Antiretrovirals and the kidney in current clinical practice
Jean Cyr Yombi, Anton Pozniak, Marta Boffito, et al.
AIDS (2014) Vol. 28, Iss. 5, pp. 621-632
Open Access | Times Cited: 101

HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment
Antonia Carroll, Bruce J. Brew
F1000Research (2017) Vol. 6, pp. 312-312
Open Access | Times Cited: 92

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study
Francis Kiweewa, Allahna Esber, Ezra Musingye, et al.
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0211344-e0211344
Open Access | Times Cited: 89

Development of an mHealth platform for HIV Care: Gathering User Perspectives Through Co-Design Workshops and Interviews
Benjamin Marent, Flis Henwood, Mary Darking
JMIR mhealth and uhealth (2018) Vol. 6, Iss. 10, pp. e184-e184
Open Access | Times Cited: 72

Hepatitis C Core Antigen Testing: A Reliable, Quick, and Potentially Cost-effective Alternative to Hepatitis C Polymerase Chain Reaction in Diagnosing Acute Hepatitis C Virus Infection
Fiona V Cresswell, Martin Fisher, D.J. Hughes, et al.
Clinical Infectious Diseases (2014) Vol. 60, Iss. 2, pp. 263-266
Open Access | Times Cited: 71

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom
Anna Tostevin, Ellen White, David Dunn, et al.
HIV Medicine (2016) Vol. 18, Iss. 3, pp. 204-213
Open Access | Times Cited: 71

ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens
David Bonsall, M. Azim Ansari, Camilla L. C. Ip, et al.
F1000Research (2015) Vol. 4, pp. 1062-1062
Open Access | Times Cited: 70

Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?
Gabrielle O’Malley, Gena Barnabee, Kenneth K. Mugwanya
Current HIV/AIDS Reports (2019) Vol. 16, Iss. 2, pp. 141-150
Open Access | Times Cited: 64

CRISPR Cas12a-Powered Silicon Surface-Enhanced Raman Spectroscopy Ratiometric Chip for Sensitive and Reliable Quantification
Haiting Cao, Jingxuan Xie, Jiayi Cheng, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 4, pp. 2303-2311
Closed Access | Times Cited: 19

Management of Chronic Hepatitis B: Canadian Association for the Study of the Liver Consensus Guidelines
Carla S. Coffin, Scott Fung, Mang Ma
Canadian Journal of Gastroenterology (2012) Vol. 26, Iss. 12, pp. 917-938
Open Access | Times Cited: 69

Global HIV‐1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
JD Baxter, David Dunn, Ellen White, et al.
HIV Medicine (2015) Vol. 16, Iss. S1, pp. 77-87
Open Access | Times Cited: 61

Deep sequencing for HIV-1 clinical management
María Casadellà, Roger Paredes
Virus Research (2016) Vol. 239, pp. 69-81
Closed Access | Times Cited: 58

2016 United Kingdom national guideline on the sexual health care of men who have sex with men
Dan Clutterbuck, David Asboe, Tristan Barber, et al.
International Journal of STD & AIDS (2018)
Open Access | Times Cited: 58

Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration
Luke C. Swenson, Bryan Cobb, Anna María Geretti, et al.
Journal of Clinical Microbiology (2013) Vol. 52, Iss. 2, pp. 517-523
Open Access | Times Cited: 57

Hypogonadism in the HIV-Infected Man
Nicholas Wong, Miles Levy, Iain Stephenson
Current treatment options in infectious diseases/Current treatment options in infectious disease (2017) Vol. 9, Iss. 1, pp. 104-116
Open Access | Times Cited: 50

Has the time come to abandon efavirenz for first-line antiretroviral therapy?
François Raffi, Anton Pozniak, M A Wainberg
Journal of Antimicrobial Chemotherapy (2014) Vol. 69, Iss. 7, pp. 1742-1747
Open Access | Times Cited: 49

Page 1 - Next Page

Scroll to top